Related Experiment Videos
Pharmacokinetics of apovincaminic acid in dogs
1Department of Pharmacokinetics and Drug Metabolism, Chemical Works of Gedeon Richter, Ltd., Budapest.
Abstract:
After the oral or intravenous administration of 10 mg vinpocetine to dogs the pharmacokinetics of its main metabolite, apovincaminic acid (AVA) can be described by a two-compartment open model. The apparent half-life of its formation was 0.56 +/- 0.23 h and that of the apparent elimination was 9.6 h which did not significantly differ from the elimination half-life of total radioactivity (8.16 +/- 1.77 h) and from the apparent elimination half-life of vinpocetine itself (8.9 +/- 2.87 h). The volume of distribution of AVA was 2.3 times lower than that of vinpocetine and its clearance value (1.5 +/- 0.77 1 h-1 kg-1) was 2.8 times less than that of vinpocetine. These results suggest that AVA does not undergo further metabolism and its elimination is formation limited.